Stephens Inc Bio Rad Laboratories, Inc. Transaction History

Stephens Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $176,268 - $211,763	421 New	421 $201,000
Q2 2022 Aug 03, 2022	SELL	$463.67 - $597.16 $41,730 - $53,744	-90 Reduced 15.9%	476 $236,000
Q1 2022 May 04, 2022	BUY	$524.57 - $735.42 $41,965 - $58,833	80 Added 16.46%	566 $319,000
Q4 2021 Mar 07, 2022	SELL	$708.84 - $794.68 $708 - $794	-1 Reduced 0.21%	486 $367,000
Q3 2021 Oct 27, 2021	SELL	$657.71 - $825.77 $23,019 - $28,901	-35 Reduced 6.7%	487 $363,000
Q2 2021 Aug 12, 2021	SELL	$576.64 - $649.04 $2,883 - $3,245	-5 Reduced 0.95%	522 $336,000
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $6,564 - $7,948	12 Added 2.33%	527 $301,000
Q4 2020 Feb 10, 2021	SELL	$510.68 - $643.45 $27,576 - $34,746	-54 Reduced 9.49%	515 $300,000
Q3 2020 Nov 13, 2020	SELL	$454.43 - $535.6 $1,363 - $1,606	-3 Reduced 0.52%	569 $293,000
Q2 2020 Aug 24, 2020	SELL	$334.87 - $493.06 $12,055 - $17,750	-36 Reduced 5.92%	572 $258,000
Q1 2020 May 14, 2020	SELL	$320.01 - $409.07 $6,400 - $8,181	-20 Reduced 3.18%	608 $213,000
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $8,312 - $9,729	-26 Reduced 3.98%	628 $232,000
Q3 2019 Oct 18, 2019	BUY	$304.55 - $345.24 $199,175 - $225,786	654 New	654 $218,000

455

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.72B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.